Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response

NCT06116461 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Erasmus Medical Center